Roivant Sciences Ltd. (ROIV) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -163.82M | -196.48M | -185.66M | -204.38M | -172.56M | -207.25M | -266.81M | -192.83M | -108.46M | -210.45M | -196.43M | -249.93M |
| Operating CF Margin % | -6500.71% | -9829.11% | -11818.2% | -9418.57% | -2279.59% | -2298.19% | -5962.15% | -2413.38% | -374.89% | -1352.35% | -5384.51% | -1155.81% |
| Operating CF Growth % | 5.07% | 5.2% | 30.41% | -5.99% | -59.11% | 1.52% | -35.83% | 22.85% | 39.44% | 5.45% | - | - |
| Net Income | 355.74M | -313.7M | -113.52M | -273.91M | -252.38M | 118.08M | -279.92M | 57.49M | -63.58M | 5.07B | -217.85M | -327.85M |
| Depreciation & Amortization | 30.24M | -8.03M | 921K | 1.1M | 1.43M | 2.92M | 4.84M | 4.88M | 2.05M | 5.38M | 7.28M | 5.84M |
| Stock-Based Compensation | 77.17M | 105M | 0 | 82.18M | 83.49M | 83.68M | 71.67M | 50.19M | 0 | 54.33M | 0 | 49.26M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -25.9M | 10.88M | -80.14M | 23.42M | -39.59M | -358.82M | -73.7M | -236.66M | -62.88M | -5.36B | -2.99M | 58.06M |
| Working Capital Changes | -601.08M | 9.37M | 7.08M | -37.17M | 34.48M | -53.1M | 10.31M | -68.73M | 15.96M | 21.2M | 17.13M | -35.24M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 16.16M | -3.99M | 3M | -11.74M | -165K | 54K | 7.21M | -25.27M | 20.89M | -8.35M | -1.8M | 11.94M |
| Cash from Investing | 134.24M | 148.72M | 120.42M | -1.09B | 1.07B | 454.07M | -3.29B | -965K | 6.93M | 5.23B | -36.45M | 105K |
| Capital Expenditures | -1.26M | 4.93M | -7.85M | -4.04M | -811K | -1.83M | -996K | -965K | -349K | -355K | -275K | -403K |
| CapEx % of Revenue | 50.04% | 246.87% | 499.55% | 185.94% | 10.71% | 20.26% | 22.26% | 12.08% | 1.21% | 2.28% | 7.54% | 1.86% |
| Acquisitions | 0 | 0 | 0 | 0 | 74.93M | 44.05M | 0 | 0 | -5.23B | 0 | -36.18M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -673.72M | 37.08M | 0 | 0 | 79K | 110.39M | 110.39M | 0 | 8.08M | 5.23B | 3K | 508K |
| Cash from Financing | -29.53M | 288.94M | 62.59M | -187.77M | -177.15M | -272.95M | -109.07M | -660.62M | -32.62M | 236.64M | 207.87M | 7.48M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | -49.09M | -1.83M | -1.83M | -7.67M | -7.66M | -7.57M | -7.81M |
| Equity Issued (Net) | -60.02M | 312.8M | 69.07M | -208.29M | -182.66M | -243.35M | -106.05M | -648.38M | 3.65M | 238.73M | 221.53M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6M | 0 |
| Share Repurchases | -111.21M | 0 | 0 | -208.29M | -295.44M | -243.35M | -106.05M | -648.38M | 0 | 0 | 0 | 0 |
| Other Financing | 30.5M | -23.86M | -6.48M | 20.52M | 5.51M | 19.49M | -1.19M | -10.4M | -28.61M | 5.57M | -86K | 15.29M |
| Net Change in Cash | -57.79M | 241.61M | -1.45M | -1.48B | 723.99M | -27.2M | -3.66B | -857.15M | -177.96M | 5.26B | -25.65M | -242.47M |
| Free Cash Flow | -165.08M | -191.55M | -193.51M | -208.42M | -173.38M | -209.08M | -267.8M | -193.79M | -108.81M | -210.81M | -196.7M | -250.34M |
| FCF Margin % | -6550.75% | -9582.24% | -12317.76% | -9604.52% | -2290.3% | -2318.45% | -5984.4% | -2425.46% | -376.1% | -1354.63% | -5392.05% | -1157.67% |
| FCF Growth % | 4.79% | 8.38% | 27.74% | -7.55% | -59.34% | 0.82% | -36.15% | 22.59% | 39.79% | 5.51% | - | - |
| FCF per Share | -0.20 | -0.27 | -0.28 | -0.31 | -0.25 | -0.29 | -0.36 | -0.25 | -0.14 | -0.25 | -0.26 | -0.33 |
| FCF Conversion (FCF/Net Income) | -0.54x | 0.74x | 1.64x | 0.92x | 0.84x | -1.22x | 1.16x | -2.02x | 0.72x | -0.04x | 0.65x | 0.86x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |